Smith & Nephew SNATS Current Ratio 2006-2018 | SNN

Current and historical current ratio for Smith & Nephew SNATS (SNN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Smith & Nephew SNATS current ratio for the three months ending June 30, 2018 was 0.00.
Smith & Nephew SNATS Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $2.66B $1.25B 2.13
2017-12-31 $2.73B $1.35B 2.03
2017-06-30 $2.58B $1.19B 2.18
2016-12-31 $2.53B $1.35B 1.88
2015-12-31 $2.48B $1.34B 1.84
2015-06-30 $2.43B $1.23B 1.99
2014-12-31 $2.44B $1.16B 2.10
2014-09-30 $2.53B $1.23B 2.06
2014-06-30 $2.53B $1.15B 2.21
2014-03-31 $2.39B $1.06B 2.25
2013-12-31 $2.26B $1.07B 2.10
2013-09-30 $2.17B $1.03B 2.11
2013-06-30 $2.08B $0.89B 2.34
2013-03-31 $2.07B $0.92B 2.26
2012-12-31 $2.14B $0.93B 2.31
2012-09-30 $2.29B $0.91B 2.52
2012-06-30 $2.09B $0.80B 2.62
2012-03-31 $2.32B $1.03B 2.26
2011-12-31 $2.21B $1.14B 1.94
2011-09-30 $2.22B $1.29B 1.73
2011-06-30 $2.24B $1.35B 1.66
2011-03-31 $2.21B $0.88B 2.51
2010-12-31 $2.15B $0.91B 2.36
2010-09-30 $2.35B $0.86B 2.72
2010-06-30 $2.15B $0.78B 2.75
2010-03-31 $2.09B $0.88B 2.38
2009-12-31 $2.09B $0.86B 2.42
2009-09-30 $2.15B $0.91B 2.37
2009-06-30 $2.09B $0.88B 2.38
2009-03-31 $2.00B $1.00B 2.00
2008-12-31 $1.99B $0.97B 2.05
2008-09-30 $1.98B $1.04B 1.90
2008-06-30 $2.06B $2.50B 0.83
2008-03-31 $2.01B $2.51B 0.80
2007-12-31 $1.91B $2.27B 0.84
2007-09-30 $1.80B $2.01B 0.90
2007-06-30 $1.77B $1.75B 1.01
2007-03-31 $1.64B $0.83B 1.97
2006-12-31 $1.65B $0.82B 2.02
2006-09-30 $1.65B $0.90B 1.83
2006-06-30 $1.70B $0.89B 1.91
2006-03-31 $1.67B $0.95B 1.77
2005-12-31 $1.71B $1.07B 1.59
2005-09-30 $1.35B $0.99B 1.36
2005-06-30 $1.36B $0.99B 1.38
2005-03-31 $1.38B $0.98B 1.40
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.007B $4.765B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00